|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,931.00 GBX | +0.86% |
|
-3.46% | +6.19% |
| 08-04 | Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says | MT |
| 08-04 | GSK : JP Morgan gives a Sell rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | +1.15% | -3.46% | +6.19% | +38.69% | +7.49% | 103B |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















